JP2009518410A5 - - Google Patents

Download PDF

Info

Publication number
JP2009518410A5
JP2009518410A5 JP2008544428A JP2008544428A JP2009518410A5 JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5 JP 2008544428 A JP2008544428 A JP 2008544428A JP 2008544428 A JP2008544428 A JP 2008544428A JP 2009518410 A5 JP2009518410 A5 JP 2009518410A5
Authority
JP
Japan
Prior art keywords
dsrna
medicament according
vaccine
animal
avian influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008544428A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/046356 external-priority patent/WO2007067517A2/en
Publication of JP2009518410A publication Critical patent/JP2009518410A/ja
Publication of JP2009518410A5 publication Critical patent/JP2009518410A5/ja
Pending legal-status Critical Current

Links

JP2008544428A 2005-12-07 2006-12-06 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA Pending JP2009518410A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74290605P 2005-12-07 2005-12-07
US75289805P 2005-12-23 2005-12-23
US79323906P 2006-04-20 2006-04-20
PCT/US2006/046356 WO2007067517A2 (en) 2005-12-07 2006-12-06 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013013055A Division JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA

Publications (2)

Publication Number Publication Date
JP2009518410A JP2009518410A (ja) 2009-05-07
JP2009518410A5 true JP2009518410A5 (https=) 2010-02-25

Family

ID=38123418

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008544428A Pending JP2009518410A (ja) 2005-12-07 2006-12-06 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA
JP2013013055A Pending JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013013055A Pending JP2013075920A (ja) 2005-12-07 2013-01-28 インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA

Country Status (6)

Country Link
US (3) US7943147B2 (https=)
EP (1) EP1957101A4 (https=)
JP (2) JP2009518410A (https=)
AU (1) AU2006322073A1 (https=)
CA (1) CA2632516C (https=)
WO (1) WO2007067517A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections
WO2005009337A2 (en) * 2003-05-16 2005-02-03 Hemispherx Biopharma Treating severe acute respiratory syndrome
WO2007067517A2 (en) * 2005-12-07 2007-06-14 Hemispherx Biopharma Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
WO2008156753A1 (en) * 2007-06-18 2008-12-24 Hemispherx Biopharma Early intervention of viral infections with immune activators
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
WO2009102496A2 (en) * 2008-02-15 2009-08-20 Hemispherx Biopharma, Inc. Selective agonist of toll-like receptor 3
WO2009127988A1 (en) * 2008-04-16 2009-10-22 Universite De Lausanne Method and vaccine for optimizing the specific immune responses
WO2009146523A1 (en) * 2008-06-05 2009-12-10 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
CN113876945A (zh) 2011-10-06 2022-01-04 免疫疫苗技术有限公司 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
CN114761558B (zh) 2019-07-02 2025-08-01 株式会社Na疫苗研究所 新型核糖核酸和基于其的药物组合物
KR102654379B1 (ko) 2019-08-28 2024-04-04 주식회사 엔에이백신연구소 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4349538A (en) * 1979-12-07 1982-09-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
US6589529B1 (en) * 1998-10-30 2003-07-08 Children's Hospital Medical Center Rotavirus subunit vaccine
GB0119346D0 (en) * 2001-08-08 2001-10-03 Bioclones Proprietary Ltd Process for the maturation of dendritic cells
CN1867355A (zh) 2003-08-11 2006-11-22 财团法人阪大微生物病研究会 包含诱导粘膜免疫的佐剂的新型疫苗
US7834064B2 (en) * 2005-01-03 2010-11-16 Andres Mario Salazar Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs
WO2007067517A2 (en) * 2005-12-07 2007-06-14 Hemispherx Biopharma Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
EP2134172A4 (en) 2007-03-05 2011-06-01 Univ Utah State RESTRICTIVE AGONIST OF THE TOLL LIKE RECEPTOR 3

Similar Documents

Publication Publication Date Title
JP6378380B2 (ja) ワクチン組成物
CY1122291T1 (el) Αναστολeις ιικου αναδιπλασιασμου
JP2009518410A5 (https=)
JP2013516450A5 (https=)
JP2009511084A5 (https=)
JP2009539965A5 (https=)
CN113304166B (zh) 核苷类化合物在制备治疗冠状病毒感染性疾病的药物中的用途
Hayden Advances in antivirals for non‐influenza respiratory virus infections
JP2011504486A5 (https=)
Cai et al. 14-Deoxy-11, 12-didehydroandrographolide attenuates excessive inflammatory responses and protects mice lethally challenged with highly pathogenic A (H5N1) influenza viruses
JP2013518107A5 (https=)
JP2013126989A5 (https=)
Budimir et al. Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
JP2012001565A5 (https=)
JP2010270130A5 (https=)
JP2022514759A5 (https=)
CN101744805B (zh) 穗花杉双黄酮作为唯一活性成分在制备治疗乙肝病毒药物中的应用
JP2019510064A5 (https=)
Kitano et al. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques
Zhu et al. Influenza virus cell entry and targeted antiviral development
JP2016520077A5 (https=)
Zheng et al. In vitro screening of traditional Chinese medicines compounds derived with anti-encephalomyocarditis virus activities
JP2009518410A (ja) インフルエンザウイルスワクチンアジュバントまたは免疫‐刺激因子としてのdsRNA
JP2010528053A (ja) インフルエンザ感染症を治療するための物質および方法
JP2014512353A5 (https=)